One, diverse academic health enterprise where people come to receive the highest quality heart and vascular care in their community while also enabling relentless innovation that fuels better health for Indiana and beyond. Read on to learn about recent advances in realizing this vision.
National Accreditation Secured for Adult Congenital Heart Disease Program
With the leadership of ACHD Medical Director, Stephen Cook, MD, we are pleased to announce that the Adult Congenital Heart Association (ACHA) has awarded the Indiana University Health Adult Congenital Heart Disease Program a status of an ACHA ACHD Accredited Comprehensive Care Center, valid for a 5-year period. Already, this program is impacting the lives of many patients in Indiana and Beyond with ACHD, many of whom require cardiac surgery in adulthood to maintain healthy, active lives.
Blake Dye Announces His Retirement
After 43 years of exceptional service in healthcare, Blake Dye, Senior Vice President for System Administration, has announced his retirement effective July 1, 2022. From the time he joined IU Health in 2018, his leadership and vision have been instrumental in the development and growth of the Cardiovascular Institute, including the successful implementation of the Heart Attack Prevention Program. He is deeply respected by his healthcare colleagues for his willingness to listen and to serve as a mentor and the Cardiovascular Institute is fortunate for his many contributions and rich experience. Please join us in congratulating Blake on his well-deserved retirement.
Welcome to Our Team
Please join us in welcoming Kimberly McClish, M.Ed., to the CV Institute to serve as the Director of Educational Initiatives for the Krannert Cardiovascular Research Center. She comes to us with several years of experience, most recently from the IU School of Medicine Emergency Medicine and Purdue University at West Lafayette in Electrical and Computer Engineering. Kimberly is passionate about education and will lead our development through strategic collaborations and research education programs.
Marisa Sepulveda's, PhD, AHA Career Development application, titled "The Role of Endothelial Serine Protease 23 and Its Post-Transcriptional Inhibitor in Ischemic Cardiac Injury", has been funded with an exceptional score for 3 years beginning April 1, 2022. In this study, they seek to understand heart protection controlled by one enzyme and its inhibitor following heart attack using human blood vessel cells. This research will show how changing the levels of the enzyme and its inhibitor can prevent muscle damage after a heart attack.
Honors and Recognitions
Dr. Kyle Frick was recently selected into IU School of Medicine's ASPIRE program. He will be collaborating with the Regenstrief Institute on a project aiming to improve cardiovascular care and outcomes by directly integrating cardiovascular disease specific health information exchange data into the electronic health record.
Watch the WRTV interview to hear what Dr. Richard Kovacs had to say about how COVID-19 increases the risk of cardiovascular disease, effecting patients of all ages.
A first-of-its-kind operation using cells from the donor's immune system to help the recipient recognize the new heart as his own. Read the NBC article to learn what Dr. Khadijah Breathett had to say.
Cheers to the OneIUCV Cardiology team that contributed to over 40 sessions at the American College of Cardiology's 71st Annual Scientific Session and Expo in Washington, DC, April 2 - 4, 2022 as presenters or panelists.
Watch Dr. Subha Raman'spresentation on COVID implications on the heart at the "Roundtable Discussion: Managing Post-COVID Symptoms for Your Patients".
The case report, recently published in JAMA Cardiology by Dr. Asad Torabi and Dr. Roopa Rao , highlights a rare complication and discusses management for a young woman who presented with shock from a viral infection and required mechanical heart support (Impella).
CV Institute is committed to bringing high value cardiovascular care to Indiana communities. Read Dr. Subha Raman's recent editorial in European Heart Journal (IF 29.98) on how we get there, and listen to a recent European Society of Cardiology podcast by her and Dr. Balaji Tamarappoo discussing a high-value tool for CV diagnosis to guide effective management.
Exciting Career Opportunities
KCVRC has, as its charge, the interdisciplinary advancement in understanding, preventing, and treating cardiovascular diseases, translating basic discoveries to favorably impact the cardiovascular health of the people of Indiana and beyond. The Center aims to advance the capabilities of high impact programmatic teams and a pipeline of talent to establish around strong pillars and cross-cutting themes in cardiovascular science.
KCVRC Major Research Areas: Themes: Ischemic Heart Disease l Rhythm Disorders l Heart Failure Pillars: Imaging l Informatics l Omics
Spread the word and refer those in your network!
For academic positions: postdoctoral fellowships, research scientists, and tenured/tenure track:
At Jobs.IU.edu browse Faculty
Click on IU School of Medicine
Search on keywords cardiology cardiovascular medicine research
For staff positions: basic, translational and clinical research, finance and administration:
At Jobs.IU.edu under the header Staff Positions
Select Current Employees or External Candidates
Keywords: cardiology cardiovascular medicine research
If you do not see a posting of interest, please refer your colleagues to firstname.lastname@example.org to inquire about upcoming opportunities.
Do you have a story that reflects the strength of our statewide system for cardiovascular care?
Please email OneIUCV@iu.edu so we can share with the team!